YOLT-101
Another single-infusion #BaseEditor therapy for Heterozygous Familial Hypercholesterolemia
From #YolTech Therapeutics

0.6 mg/kg N=3
Being effective in 1 wk
Sustained 70% ⬇️plasma PCSk9 & 50% ⬇️LDL-C till 16-wk

medRxiv 2025
www.medrxiv.org/content/10.1...

Check this out if you're interested in #crispr #baseeditor. Congratulations Cansu for creating this wonderful tool.

🚨 Excited to share our latest preprint!
@mgarnett.bsky.social @mattcoelho.bsky.social
We introduce BEstimate, a flexible, comprehensive tool for designing and interpreting CRISPR-based editing experiments.
#CRISPR #BEstimate #BaseEditor

Design & Deliver #CRISPR #BaseEditor #PrimeEditor to your adult👤stem cell-derived (colon/ endometrium/hepatocyte) #Organoids

Plasmids
Electroporation
FACS + PiggyBac selection

Learn "Picking the right genome editing tool in 30 minutes!"😄
#STARProtocols 2024
star-protocols.cell.com/protocols/3589